Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 on the page, indicating a new build of the ClinicalTrials.gov history view. This update is a metadata/version change and does not alter study data, records, or user-facing functionality.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the version history, updating the record with current recruitment status and location details. The revision is v3.5.2.SummaryDifference0.4%

- Check49 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry (v3.4.3) was added to the history, replacing the previous entry (v3.4.2).SummaryDifference0.1%

- Check91 days agoChange DetectedThe history shows a new site revision, v3.4.2, replacing the previous v3.4.1 notice about government funding and operating status. The old funding-status notice has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check98 days agoChange DetectedAdded a site-wide notice about government funding and updated the revision to v3.4.1. Removed the previous revision entry v3.4.0.SummaryDifference0.5%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.